Please use this identifier to cite or link to this item:
|Title:||An evidence-based update on nonsteroidal anti-inflammatory drugs||Authors:||Ong, C.K.S.
COX-2 specific inhibitors
|Issue Date:||2007||Citation:||Ong, C.K.S., Lirk, P., Tan, C.H., Seymour, R.A. (2007). An evidence-based update on nonsteroidal anti-inflammatory drugs. Clinical Medicine and Research 5 (1) : 19-34. ScholarBank@NUS Repository. https://doi.org/10.3121/cmr.2007.698||Abstract:||Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs.This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed. ©2007 Marshfield Clinic.||Source Title:||Clinical Medicine and Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/46659||ISSN:||15394182||DOI:||10.3121/cmr.2007.698|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 19, 2021
checked on Feb 16, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.